Atelocollagen is a type of collagen protein that has undergone specific treatment (protease dissolution), and its physical properties are similar to those of untreated natural collagen protein, while exhibiting some superior properties.

Overview of Market Development

In recent years, with the improvement of health awareness and the advancement of biotechnology, the market size of atelocollagen has gradually expanded. Especially in the fields of health products, pharmaceuticals, food and beverage, cosmetics, etc., de terminated peptide gels are favored due to their various benefits. According to our research data, the estimated revenue of the global atelocollagen market in 2024 is 1165 million, an increase of 8.48% compared to 2023.

In the future, with the further improvement of consumer health awareness and the intensification of population aging trends, as well as the continuous advancement of biotechnology and the expansion of application fields, it is expected that the market will continue to expand. By 2029, the revenue of the global atelocollagen market is expected to increase to 1761 million. The CAGR for 2024-2029 is estimated to be 8.61%.

Segmented Market Analysis

From the perspective of product types, according to different sources, atelocollagen can be divided into bovine atelocollagen and porcine atelocollagen. Among them, bovine atelocollagen holds the highest market share, estimated to be 55.33% in 2024.

From the perspective of downstream application patterns, atelocollagen is mainly used in medical, beauty and other fields. Among them, the medical field is the largest downstream application market, with an expected application share of 78.19% in 2024.

 

Source: www.globalmarketmonitor.com

Analysis of Market Competition Pattern

From the perspective of market competition, the concentration of the global atelocollagen market is high. Data shows that in 2023, the top 3 companies had a total revenue of $634 million from the atelocollagen market, accounting for 59.00% of the total revenue. The top three companies are Integra LifeSciences, DSM Biomedical, and Collagen Matrix. In 2023, these three companies' revenue shares in the global atelocollagen market were 31.62%, 19.19%, and 8.19%, respectively.